1023 related articles for article (PubMed ID: 19699872)
1. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
[TBL] [Abstract][Full Text] [Related]
2. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
[TBL] [Abstract][Full Text] [Related]
5. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients.
Dekker LR; Bezzina CR; Henriques JP; Tanck MW; Koch KT; Alings MW; Arnold AE; de Boer MJ; Gorgels AP; Michels HR; Verkerk A; Verheugt FW; Zijlstra F; Wilde AA
Circulation; 2006 Sep; 114(11):1140-5. PubMed ID: 16940195
[TBL] [Abstract][Full Text] [Related]
6. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
Ottervanger JP; Ramdat Misier AR; Zijlstra F; Schalij MJ; Wever E; Jordaens LJ; Henriques JP; de Boer MJ; Robbe HW; Wellens HJ;
Am Heart J; 2006 Oct; 152(4):636-40. PubMed ID: 16996827
[TBL] [Abstract][Full Text] [Related]
7. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
[TBL] [Abstract][Full Text] [Related]
8. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
[TBL] [Abstract][Full Text] [Related]
9. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
[TBL] [Abstract][Full Text] [Related]
10. Mortality in patients with left ventricular ejection fraction Ottervanger JP; Ramdat Misier AR; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; Reiffers S; van 't Hof AW;
Am J Cardiol; 2007 Sep; 100(5):793-7. PubMed ID: 17719322
[TBL] [Abstract][Full Text] [Related]
11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
12. Comparison of left ventricular ejection fraction and inducible ventricular tachycardia in ST-elevation myocardial infarction treated by primary angioplasty versus thrombolysis.
Chong JJ; Ganesan AN; Eipper V; Kovoor P
Am J Cardiol; 2008 Jan; 101(2):153-7. PubMed ID: 18178398
[TBL] [Abstract][Full Text] [Related]
13. Ventricular fibrillation in acute myocardial infarction before and during primary PCI.
Henriques JP; Gheeraert PJ; Ottervanger JP; de Boer MJ; Dambrink JH; Gosselink AT; van 't Hof AW; Hoorntje JC; Suryapranata H; Zijlstra F
Int J Cardiol; 2005 Dec; 105(3):262-6. PubMed ID: 16274766
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
15. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
[TBL] [Abstract][Full Text] [Related]
16. Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
Schoenenberger AW; Kobza R; Jamshidi P; Zuber M; Abbate A; Stuck AE; Pfisterer M; Erne P
Am J Cardiol; 2009 Jul; 104(2):158-63. PubMed ID: 19576339
[TBL] [Abstract][Full Text] [Related]
17. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
18. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
Kozieradzka A; Kamiński K; Dobrzycki S; Nowak K; Musiał W
Kardiol Pol; 2007 Jul; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
[TBL] [Abstract][Full Text] [Related]
20. Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry.
Bougouin W; Marijon E; Puymirat E; Defaye P; Celermajer DS; Le Heuzey JY; Boveda S; Kacet S; Mabo P; Barnay C; Da Costa A; Deharo JC; Daubert JC; Ferrières J; Simon T; Danchin N;
Eur Heart J; 2014 Jan; 35(2):116-22. PubMed ID: 24258072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
